EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Multizentrische Studie

Upper Airway Stimulation for Children and Adolescents with Down Syndrome: Long‐Term Follow‐Up

Danielle R Larrow iD, Kathryn S Marcus iD, Kevin Gipson, Brian G Skotko, Cristina M Baldassari iD, David F Smith iD, Christine H Heubi iD, Allison Tobey, Raol Nikhila iD, Mark Vangel, Christopher J Hartnick iD

The Laryngoscope · 2025

DOI: 10.1002/lary.31828 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift The Laryngoscope, 2025. Verfasst von Danielle R Larrow und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, U.S.A. Hauptthemen laut MEDLINE: Down Syndrome, Electric Stimulation Therapy, Hypoglossal Nerve, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective(s) Hypoglossal nerve stimulation (HGNS) is safe and effective for patients with Down syndrome (DS) and severe persistent obstructive sleep apnea (OSA). Long‐term outcomes for this patient population have not been evaluated.

Methods

A prospective single‐group multicenter cohort study with 1‐year follow‐up was conducted between 2015 and 2021 among 42 adolescent patients with DS and severe persistent OSA. Here, we evaluate long‐term outcomes in this patient cohort. Patients were evaluated with polysomnogram (PSG) at three timepoints: pre‐implantation (timepoint 1), 1‐year post‐implantation (timepoint 2), and long‐term follow‐up (timepoint 3).

Results

Long‐term follow‐up data were available for 33 of 42 patients. Mean (SD) of timepoint 3 was 4.0 (1.9) years after implantation. Using a therapy response definition of a 50% decrease in Apnea Hypopnea INdez (AHI) from timepoint 1, the response rate was 69.7% (23/33) at timepoint 2 and 87.9% (29/33) at timepoint 3. From timepoint 1, there was a mean (SD) decrease in AHI of 12.7 (13.4) events/h at timepoint 2 and 15.7 (13.1) events/h at timepoint 3. The mean percentage change in AHI between timepoints 1 and 2 was −51.1% (95% CI: −32.8% to −69.3%) and between timepoints 1 and 3 was −59.6% (95% CI: −42.0% to −77.3%).

Conclusion

Patients with DS and severe persistent OSA who undergo HGNS implantation may continue to experience improvement in PSG parameters at long‐term follow‐up. Future studies are needed to assess additional long‐term outcomes in this patient population, including neurocognition and quality of life. Level of Evidence 3 Laryngoscope , 135:1218–1222, 2025

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeElectric Stimulation TherapyHypoglossal NerveSleep Apnea, ObstructiveAdolescentChildFemaleHumansMaleFollow-Up StudiesPolysomnographyProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

Down syndromehypoglossal nerve stimulationobstructive sleep apneaupper airway stimulation

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, U.S.A.
  • Division of Pediatric Pulmonology and Sleep Medicine, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
  • Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, U.S.A.
  • Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
  • Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, U.S.A.
  • Department of Otolaryngology-Head and Neck Surgery, Cincinnati Children's Hospital, Cincinnati, Ohio, U.S.A.

ORCID-Profile: Danielle R Larrow, Kathryn S Marcus, Cristina M Baldassari, David F Smith, Christine H Heubi, Raol Nikhila, Christopher J Hartnick

Zitieren

APA

Larrow, D. R., Marcus, K. S., Gipson, K., Skotko, B. G., Baldassari, C. M., Smith, D. F., Heubi, C. H., Tobey, A., Nikhila, R., Vangel, M., & Hartnick, C. J. (2025). Upper Airway Stimulation for Children and Adolescents with Down Syndrome: Long‐Term Follow‐Up. The Laryngoscope. https://doi.org/10.1002/lary.31828

Vancouver

Larrow DR, Marcus KS, Gipson K, Skotko BG, Baldassari CM, Smith DF, et al. Upper Airway Stimulation for Children and Adolescents with Down Syndrome: Long‐Term Follow‐Up. The Laryngoscope. 2025. doi:10.1002/lary.31828

BibTeX
@article{Larrow2025,
  author = {Larrow, Danielle R and Marcus, Kathryn S and Gipson, Kevin and Skotko, Brian G and Baldassari, Cristina M and Smith, David F and Heubi, Christine H and Tobey, Allison and Nikhila, Raol and Vangel, Mark and Hartnick, Christopher J},
  title = {Upper Airway Stimulation for Children and Adolescents with Down Syndrome: Long‐Term Follow‐Up},
  journal = {The Laryngoscope},
  year = {2025},
  doi = {10.1002/lary.31828}
}
Kostenlos starten →